Fundamental analysis LMRI (Lumexa Imaging Holdings Inc)

Updated on 06/09/2026

We analyzed Lumexa Imaging Holdings stock against the 10 quality criteria of Lubin Investment. The company gets a quality score of 4/10, meaning low quality.

Sector: Medical Devices. Listing: US. Current price: 8.13 USD.

Lubin scoring methodology

Lumexa Imaging Holdings Inc (LMRI)'s score is calculated automatically from 10 objective financial criteria, with no human intervention or opinion. Each criterion is validated (YES / PARTIAL / NO) based on thresholds drawn from the financial literature (Warren Buffett, Bettin-Mauboussin, Aswath Damodaran). The final score is the sum of validations.

The 10 quantitative criteria analyzed

1. Profitable: positive net margin
2. Growing revenue: revenue growing > 10%/year over 5 years
3. Growing earnings per share: FCF per share adjusted for stock-based compensation, > 10%/year over 5 years
4. Share count under control: stable or declining (net buybacks = value creation for shareholders)
5. Cash profitability: free cash flow margin > 10% of revenue
6. Expanding margins: operating margin widens over 5 years (operating leverage)
7. Return on invested capital: Bettin-Mauboussin Cash ROCE > 15% per year
8. Debt under control: net debt repayable in less than 3 years of free cash flow
9. Earnings converted to cash: free cash flow exceeds accounting net income
10. Net collection period: short or negative cash conversion cycle

Frequently asked questions

Is Lumexa Imaging Holdings a quality stock?

Lumexa Imaging Holdings gets a quality score of 4/10 (low quality), calculated over the 10 Lubin Investment criteria: profitability, revenue and free cash flow growth, share buybacks, margins, debt and return on capital.

How is Lumexa Imaging Holdings's score calculated?

The score is the total of validated criteria (YES / PARTIAL / NO) using thresholds drawn from the financial literature (Warren Buffett, Mauboussin, Aswath Damodaran), automatically and with no human opinion.

Where to see Lumexa Imaging Holdings's full analysis?

The full interactive analysis (10-criteria detail, history, P/FCF valuation, sector comparisons) is available at https://lubin-investment.com/analyse/LMRI?lng=en.

Other stocks in the Medical Devices sector

• STERIS (STE) — score 10/10, P/FCF 22.8×
• Haemonetics (HAE) — score 10/10, P/FCF 11.7×
• Stryker (SYK) — score 10/10, P/FCF 27.1×
• Dexcom (DXCM) — score 10/10, P/FCF 22.3×
• Smith & Nephew (SNN) — score 9/10, P/FCF 15.7×

Go further

👉 See the full interactive analysis of LMRI

Other resources : Detailed methodology · All stocks in the Medical Devices sector · Stocks rated 10 out of 10 · Top quality companies · Lubin Investment pricing.